These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 26888385)

  • 21. Immunohistochemistry for the differential diagnosis of renal tumors with oncocytic features.
    Fernández-Aceñero MJ; Cazorla A; Manzarbeitia F
    Urol Oncol; 2011; 29(5):545-9. PubMed ID: 19926310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
    Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
    Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
    Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
    Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray.
    Abrahams NA; MacLennan GT; Khoury JD; Ormsby AH; Tamboli P; Doglioni C; Schumacher B; Tickoo SK
    Histopathology; 2004 Dec; 45(6):593-602. PubMed ID: 15569050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis.
    Mete O; Kilicaslan I; Gulluoglu MG; Uysal V
    Virchows Arch; 2005 Dec; 447(6):938-46. PubMed ID: 16133362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinoma.
    Zheng G; Chaux A; Sharma R; Netto G; Caturegli P
    Exp Mol Pathol; 2013 Feb; 94(1):29-32. PubMed ID: 22705098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?
    Ng KL; Del Vecchio SJ; Samaratunga H; Morais C; Rajandram R; Vesey DA; Wood ST; Gobe GC
    Pathology; 2018 Aug; 50(5):504-510. PubMed ID: 29970253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic utility of vimentin, CD117, cytokeratin-7 and caveolin-1 in differentiation between clear cell renal cell carcinoma, chromophobe renal cell carcinoma and oncocytoma.
    El-Shorbagy SH; Alshenawy HA
    J Microsc Ultrastruct; 2017; 5(2):90-96. PubMed ID: 30023241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of GPNMB in renal eosinophilic tumors and its value in differential diagnosis].
    Wang Y; Hou MY; Fu Y; Meng K; Wu HY; Chen J; Xu YM; Shi J; Fan XS
    Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):358-363. PubMed ID: 36973196
    [No Abstract]   [Full Text] [Related]  

  • 30. Oncocytic renal neoplasms: diagnostic considerations.
    Abrahams NA; Tamboli P
    Clin Lab Med; 2005 Jun; 25(2):317-39, vi. PubMed ID: 15848739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of immunohistochemical analysis of KAI1, epithelial-specific antigen, and epithelial-related antigen for distinction of chromophobe renal cell carcinoma, an eosinophilic variant from renal oncocytoma.
    Ohe C; Kuroda N; Takasu K; Senzaki H; Shikata N; Yamaguchi T; Miyasaka C; Nakano Y; Sakaida N; Uemura Y
    Med Mol Morphol; 2012 Jun; 45(2):98-104. PubMed ID: 22718295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression of heterochromatin protein 1α/β in the kidney tumors: a microarray immunohistochemical study.
    Han B; Ziober A; Lu S; Bing Z
    Ann Diagn Pathol; 2013 Apr; 17(2):172-5. PubMed ID: 23142018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis.
    Liu L; Qian J; Singh H; Meiers I; Zhou X; Bostwick DG
    Arch Pathol Lab Med; 2007 Aug; 131(8):1290-7. PubMed ID: 17683191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of carbonic anhydrase IX, PAX2 and PAX8 and their association with clinicopathologic characteristics in renal epithelial tumors].
    Zhang W; Yu WJ; Xia Y; Liu Y; Liu XL; Zhuang J; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):442-5. PubMed ID: 24246861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring Multiphoton Microscopy as a Novel Tool to Differentiate Chromophobe Renal Cell Carcinoma From Oncocytoma in Fixed Tissue Sections.
    Jain M; Robinson BD; Wu B; Khani F; Mukherjee S
    Arch Pathol Lab Med; 2018 Mar; 142(3):383-390. PubMed ID: 29219617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma.
    Wang HY; Mills SE
    Am J Surg Pathol; 2005 May; 29(5):640-6. PubMed ID: 15832088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review and meta-analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytoma.
    Ng KL; Morais C; Bernard A; Saunders N; Samaratunga H; Gobe G; Wood S
    J Clin Pathol; 2016 Aug; 69(8):661-71. PubMed ID: 26951082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
    Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
    Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimitochondrial antibody (113-1) in the differential diagnosis of granular renal cell tumors.
    Tickoo SK; Amin MB; Linden MD; Lee MW; Zarbo RJ
    Am J Surg Pathol; 1997 Aug; 21(8):922-30. PubMed ID: 9255255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases.
    Cochand-Priollet B; Molinié V; Bougaran J; Bouvier R; Dauge-Geffroy MC; Deslignières S; Fournet JC; Gros P; Lesourd A; Saint-André JP; Toublanc M; Vieillefond A; Wassef M; Fontaine A; Groleau L
    Arch Pathol Lab Med; 1997 Oct; 121(10):1081-6. PubMed ID: 9341588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.